UK MHRA Outlines Regulatory Framework for Microbiome-Based Medicines
The UK Medicines and Healthcare products Regulatory Agency (MHRA) publishes a position paper outlining the UK licensing route for microbiome-based medicines, helping developers advance innovative therapies to patients.
MHRA Regulatory Framework | 19/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy